###### Strengths and limitations of this study

-   This will be the first randomised controlled trial to compare the clinical effectiveness of a novel individualised treatment called cognitive functional therapy with a combined exercise and pain education class in people with non-specific chronic low back pain (NSCLBP).

-   Methodological qualities of the trial include: three intervention sites, blinded assessment and concealed allocation, an active comparison group, long-term follow-up, appropriate sample size calculation, treatment fidelity measures and a planned intention-to-treat analysis.

-   Only patients with NSCLBP greater than 6 months will be included, and while inclusion and exclusion criteria are broad, the study results will not be generalisable to all people with low back pain.

-   Therapist and patient blinding is not possible.

Introduction {#s1}
============

Non-specific chronic low back pain (NSCLBP) is a very common and costly musculoskeletal disorder, resulting in significant personal, social and economic burden.[@R1] There is strong evidence that NSCLBP is associated with a complex interaction of factors. These include physical factors (eg, maladaptive postures and movement patterns, altered body perception, pain behaviours and deconditioning),[@R4] cognitive factors (eg, unhelpful beliefs, catastrophising, hypervigilance, maladaptive coping strategies, poor self-efficacy),[@R9] psychological factors (eg, fear, anxiety, depression),[@R15] lifestyle factors (eg, physical inactivity, sleep problems, chronic life stress),[@R19] neurophysiological factors (eg, peripheral and central nervous system sensitisation),[@R23] and social factors (eg, socioeconomic status, family, work and culture).[@R28] [@R29] Despite this complex interaction of factors in NSCLBP, with many of these factors being potentially modifiable, most current interventions neither target multiple aspects of an individual\'s pain experience nor individualise the targeting of such factors for each patient.[@R30] [@R31] Therefore, it is not surprising that treatments such as manual therapy, exercise, medications, relaxation, cognitive behavioural therapy and acceptance and commitment therapy, while reducing disability and enhancing quality of life to an extent, are not superior to each other and have a limited impact on pain in the long term.[@R32]

Cognitive functional therapy (CFT) is a novel, patient-centred behavioural intervention which addresses multiple aspects in NSCLBP. This approach focuses on changing patient beliefs, confronting their fears, educating them about pain mechanisms, enhancing mindfulness of the control of their body during pain provocative functional tasks, training them to reduce excessive trunk muscle activity and change behaviours related to pain provocative movements and postures.[@R31] In a recent randomised controlled trial (RCT) among people with moderate NSCLBP, this approach was significantly more effective than combining manual therapy and exercise.[@R39] Similar results were demonstrated for a high-risk group of patients with NSCLBP treated with CFT in a recent single-centre cohort study in Ireland.[@R40] However, a range of RCTs have suggested that class-based treatments are as effective as individualised treatment in musculoskeletal pain populations,[@R41] including NSCLBP. In addition, many people with chronic musculoskeletal pain, including NSCLBP, appear to be either over-treated or treated inefficiently, without this additional one to one intervention necessarily improving their outcome.[@R53] Therefore, it is important to examine whether an individualised intervention, such as CFT, is demonstrative of clinical-effectiveness as compared to a relatively cheap comparison treatment such as a combined exercise and pain education class.

Objectives {#s2}
==========

Primary objective {#s2a}
-----------------

The primary objective is to examine the clinical effectiveness of CFT, based on whether participants in the CFT arm report significant improvements in the short, medium and long term on measures of functional disability and pain intensity, relative to those allocated to combined exercise and pain education classes.

Secondary objectives {#s2b}
--------------------

The secondary objectives include examining whether CFT has a significant effect on costs relative to classes in the short, medium and long term, and examining mediators (back pain beliefs, fear, coping, self-efficacy, sleep, depression, anxiety, stress and treatment satisfaction) as well as moderators and predictors (demographic information (age, sex, duration of CLBP), socioeconomic status, baseline risk of chronicity, number of pain areas and general health symptoms) of treatment effect across both interventions.

Methods and analysis {#s3}
====================

Design and setting {#s3a}
------------------

The design is a three site RCT comparing individualised CFT and a class-based intervention. The sites are two primary care centres (Ballina Primary Care Centre and Claremorris Primary Care Centre) and one public hospital (Mayo General Hospital) that receives referrals from both medical consultants in secondary care and primary care general practitioners (GPs) in Ireland. Any modifications to the protocol which may impact on the conduct of the study will require a formal amendment to the protocol. Such amendment will be agreed on by the project management committee (MOK, KOS, NK, POS, HP and NB) and approved by the relevant ethics committee prior to the implementation of the modifications. Minor administrative changes to the protocol will be agreed on by the project management committee and will be documented in a memorandum.

Ethical considerations {#s3b}
----------------------

Ethical approval has been granted by the relevant hospital research ethics committee (MGH-14-UL). Written informed consent will be obtained from all participants included in the study. Participants will be informed that they are not obliged to take part in the study and are free to withdraw at any time, without any negative consequences on their future care. All efforts will be made to protect the privacy of the participants, and to keep their names and personal information confidential at all times. This will be achieved by referring to all participant records and information only by their assigned research code. No significant adverse reactions are anticipated in the study, but these will be monitored. Both interventions will involve some exercise. This involves a very small risk of increased stiffness and soreness initially. However, all exercise will be performed at a speed and intensity under the participant's own control. The suitability of exercise for the participants will be assessed at entry to the study by the treating physiotherapist.

Recruitment and participants {#s3c}
----------------------------

Participants who are referred to the physiotherapy service in each site will be screened individually for 15--20 min. Participants meeting the eligibility criteria will be recruited. All participants will be given the option of receiving usual care physiotherapy (individualised) or taking part in the study. Those interested in participating will be presented with written information about the study, including its aims and procedures (see online supplementary file 1). Here it is clearly stated that there are two active intervention arms and that based on current knowledge, it is not known which intervention is superior. The patients will provide written informed consent prior to randomisation (see online supplementary file 2). The inclusion/exclusion criteria are described in [table 1](#BMJOPEN2014007156TB1){ref-type="table"}.

###### 

Inclusion and exclusion criteria for study participation

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Inclusion criteria                                                                                              Exclusion criteria
  --------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ▸ Aged between 18 and 75\                                                                                       ▸ Primary pain area is not the lumbar spine (from T12 to buttocks)\
  ▸ Chronic low back pain for at least 6 months duration\                                                         ▸ Leg pain as the primary problem (eg, nerve root compression or disc prolapse with true radicular pain/radiculopathy, lateral recess or central spinal stenosis)\
  ▸ Score of 14% or more for disability on the Oswestry Disability Index (ODI)\                                   ▸ Less than 6 months after lumbar spine, lower limb or abdominal surgery\
  ▸ Independently mobile (with or without aids), to be capable of participating in a rehabilitation programme\    ▸ Pain relieving procedures such as injection-based therapy (eg, epidurals) and day case procedures (eg, rhizotomy) in the past 3 months\
  ▸ Be able to speak and understand English well enough to be able to complete the questionnaires independently   ▸ Pregnancy\
                                                                                                                  ▸ Rheumatological/inflammatory disease (eg, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, lupus erythematosus, Scheuermann\'s disease)\
                                                                                                                  ▸ Progressive neurological disease (eg, multiple sclerosis, Parkinson's disease, motor neuron disease)\
                                                                                                                  ▸ Scoliosis (if considered the primary driver of pain)\
                                                                                                                  ▸ Unstable cardiac conditions\
                                                                                                                  ▸ Red flag disorders like malignancy/cancer, acute traumas like fracture (less than 6 months ago) or infection, spinal cord compression/cauda equina

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Treatment allocation and randomisation {#s3d}
--------------------------------------

To ensure concealment of allocation, patients will only be randomised to receive the individualised CFT or the class-based intervention after it is clear that they meet the inclusion criteria. Allocation will be picked from an opaque envelope. The envelope will contain only two pieces of paper. Participants will be asked to pick one piece of paper from the envelope. One piece of paper will have the letter 'C' for class and the other, letter 'I' for individual CFT. The number of participants who choose to withdraw from the study at this, or any other, stage will be recorded. Participant progress through the study is shown in [figure 1](#BMJOPEN2014007156F1){ref-type="fig"}.

![Trial design.](bmjopen2014007156f01){#BMJOPEN2014007156F1}

Baseline assessments {#s3e}
--------------------

At the initial screening assessment when patients are screened for eligibility, all will have to complete the ODI[@R58] to ensure they meet the criteria for inclusion. If eligible, and participants consent to participate after random allocation, they then complete the remaining sections of the questionnaire (see below) before their first intervention session which is within 2 weeks of the date of screening. In the event that their appointment is longer than 2 weeks after the initial screening session, they will recomplete all the questionnaires on the day of the first intervention session. The second of these baseline assessments will be used as baseline. In the event of an individual\'s ODI being less than 14%, they will remain in the study since they have already been randomised.

Interventions {#s4}
=============

All interventions will be provided by three physiotherapists (AT, LD and LA), with one physiotherapist working in each location. The treating physiotherapists have been trained to deliver the interventions to enhance standardisation of interventions. Training involved a blended learning approach, including interactive lectures and seminars, as well as clinical workshops where the management of NSCLBP as a multidimensional biopsychosocial disorder was discussed. Both interventions use a biopsychosocial approach.

The specific training for the CFT intervention involved the treating physiotherapists (1) observing CFT-trained tutors (<http://www.pain-ed.com>) assess and treat real patients with NSCLBP using CFT, and (2) assessing and treating patients with NSCLBP in front of the same CFT tutors. The specific training for the class-based intervention involved the development of a series of six classes, each including exercise and education. Discussions between the three treating physiotherapists and two of the study authors (KOS and MOK) will take place to ensure effective and consistent delivery across sites.

For both intervention arms, treating physiotherapists piloted the interventions until they were deemed competent to deliver the interventions. Treating physiotherapists were also provided with additional resources to support both the interventions, including written and web-based resources (eg, <http://www.pain-ed.com>) regarding the biopsychosocial nature of pain, the limited role of imaging in NSCLBP, and the role of behavioural changes such as activity, stress management and sleep hygiene in managing NSCLBP.

Experimental intervention: individualised CFT {#s4a}
---------------------------------------------

The CFT intervention will be one to one, will involve hearing the full patient story regarding their pain, and the intervention will be targeted to meet the participants' individual needs. All participants randomised to this group will undergo a comprehensive one-to-one interview and physical examination by the treating physiotherapist. This detailed examination will be essential in order to broadly identify the modifiable multidimensional drivers of pain and disability (pain provocative cognitive, movement and lifestyle behaviours) for each participant.[@R39] [@R40] [@R59]

During the interview, participants will be asked to provide information about their history of pain, pain area and nature, pain behaviour (aggravating/easing movements and activities), their primary functional impairments, disability, activity levels, lifestyle behaviours and sleep patterns. Participants will be also be questioned about their level of fear of pain and any avoidance of activities, work and social engagement. Their degree of pain focus, pain coping strategies, stress response and its relationship to pain, and their pain beliefs will also be established as will be any history of anxiety and depression. Finally, their beliefs and goals regarding management of their disorder will be ascertained.[@R39] [@R40] [@R59]

The physical examination will involve analysis of the participants' primary functional impairments (eg, pain provocative, feared and/or avoided movements and functional tasks as reported during the interview), in order to identify maladaptive behaviours which include muscle guarding, 'abnormal' movements and postures, avoidant patterns and pain behaviours. They will also be assessed regarding their level of body control and awareness (body perception), as well as their ability to relax their trunk muscles and normalise pain provocative postural and movement behaviours, and the effect this has on their pain.[@R39] [@R40] [@R59]

Treatment will be provided in the local physiotherapy department at each site. The initial session will last approximately 1 h and follow-up sessions will range from 30 min to 1 h. Treatment frequency will vary pragmatically with each patient, though it is expected that appointments will start weekly and reduce in frequency over time. Similarly, treatment duration will vary from approximately 4 to 16 sessions. While 16 is the anticipated upper limit of sessions, eight is the expected average. The duration, and number, of treatments will be recorded. Each patient will receive an individualised targeted intervention directed at changing their individual cognitive, movement and lifestyle behaviours considered to be provocative and maladaptive of their disorder.[@R6] [@R31] [@R60] There will be four main components to the intervention. These will be: A cognitive component will focus on the factors identified from the examination that are considered to contribute to their pain disorder. This will include discussing the multidimensional nature of persistent pain as it pertains to the individual---and how beliefs, emotions and behaviours (movement and lifestyle) can reinforce a vicious cycle of pain sensitisation and disability. The various factors of the vicious cycle will be outlined in a personalised diagram for each participant based on the findings from the examination. Where considered appropriate, patients will be advised to read resources and watch patient videos on <http://www.pain-ed.com> and will be given leaflets on sleep, relaxation and mindfulness, the role of spinal imaging, such as MRIs, and regarding exercise and physical activity if these are considered relevant to their pain presentation by the treating physiotherapist.Specific functional training will be designed to normalise maladaptive and provocative postural and movement behaviours as directed by the patient\'s individual presentation. This will involve a behavioural modification approach to rehabilitation where patients will be taught strategies aimed to enhance their body awareness and control in order to relax, and modify postures and tasks they report as being pain provocative. Where considered appropriate, patients will be given audio resources (eg, mindfulness CDs) to facilitate this process.Targeted functional integration into daily life activities which are avoided by, and/or provocative for, the patient. This will vary between individuals, but will be likely to include targeting activities such as rolling in bed, sitting, standing up from sitting, walking, bending and lifting.Physical activity and lifestyle advice will include promotion of gradually increasing physical activity based on their preference and presentation, advice on sleep hygiene, stress management strategies and social re-engagement.[@R39] [@R40] [@R59]

A key component underlying each of these four stages which may facilitate patients achieving a positive outcome will be maximising the contextual or 'non-specific' aspects of treatment. This will include using motivational interviewing techniques,[@R61] as well as establishing and demonstrating empathy with the patient to enhance patient--therapist rapport and interaction.[@R62] All instructions for participants will be written, when deemed appropriate by the physiotherapist and/or requested by the participants.

Control intervention: combined exercise and pain education class {#s4b}
----------------------------------------------------------------

This class-based intervention will not involve individual assessment or consideration of the patient\'s story. All participants in this class will receive the same intervention and it will not be specifically targeted to their individual needs.

The class-based intervention will consist of six classes over 6--8 weeks, each lasting approximately 1 h and 15 min, with up to 10 participants in each class. It will have biopsychosocially orientated sessions involving education, exercise and relaxation/mindfulness. Everybody will have the opportunity to ask questions and answers will be provided for the whole class. It differs from the individualised CFT in that it is not targeted to the individual, it does not involve one-to-one attention, and everybody gets the same advice and functional activation exercises. Each class will start with a 30 min discussion, using a different focus/topic each week. The topics to be covered will include explaining contemporary understanding of pain and the role of the nervous system,[@R63] the multidimensional nature of CLBP and common myths about CLBP, posture and ergonomics, exercise, relaxation and sleep. All talks will involve the use of visual aids (eg, slides, flipcharts) and a copy of the slides from every class will be provided to participants. The second part of the class will be a 40 min gradually progressive exercise circuit involving aerobic, flexibility and strengthening exercises, similar to the class-based intervention delivered in a previous RCT.[@R64] The exercises will be step-ups, squats, sit to stands, marching/jogging on spot, wall push-ups, hip lift/bridging, knees to chest/lumbar flexion, rolling knee to side/lumbar rotation, the cat stretch and the hip flexor lunge stretch. Participants will be instructed to do the exercises at their own desired pace. No special equipment will be needed. All participants will be given a copy of these exercises to do at home and will be encouraged to do these once a day. Finally, a 5 min relaxation/mindfulness component will take place at the end of each class. In addition, all participants will be advised to watch patient videos and read resources on <http://www.pain-ed.com>, and will receive the aforementioned leaflets on sleep, relaxation and mindfulness, the role of spinal imaging, such as MRI, and on exercise and physical activity. Efforts will be made to enhance the 'non-specific' aspects of treatment by creating an open atmosphere, encouraging patient interaction, engagement and opportunity for questions and input.

Outcome measures {#s5}
================

All outcome measures will be self-reported and will be conducted preintervention (see online supplementary file 3), postintervention (see online supplementary file 4) as well as 6 and 12 months (see online supplementary file 5) after randomisation. The primary outcome measures selected for this study are based on the Initiative on Methods, Measurement and Pain Assessment in Clinical Trials (IMMPACT) recommendations for outcome measures for chronic pain clinical trials. The rate of attrition among the participants during their completion of the intervention will be recorded.

Primary outcomes {#s5a}
----------------

The two primary outcomes of interest will be functional disability and pain intensity. Functional disability will be measured using the ODI, a validated 10-item questionnaire.[@R58] Pain intensity will be assessed using the Numeric Rating Scale, a validated 0--10 scale.[@R65] Participants will asked to rate their pain on average during the past week; 0 representing no pain and 10 representing pain as bad as you can imagine. Both will be assessed at all time-points (baseline, postintervention, as well as 6 and 12 months after randomisation).

Secondary outcomes {#s5b}
------------------

The secondary outcome of interest will be costs. Treatments and tests received, hospitalisations and tests, medications, equipment, aids and informal care, travel costs, employment status and work absenteeism will be assessed. The number and length of treatment sessions will also be documented by the treating physiotherapists. This will be assessed at 6 and 12 months (see online supplementary file 6).

Mediators of outcome {#s5c}
--------------------

*Beliefs*: Beliefs about back pain will be assessed using the nine-item Back Beliefs Questionnaire.[@R66]*Fear*: this will be measured using the four-item physical activity subscale of the Fear-Avoidance Beliefs Questionnaire.[@R67]*Coping*: this will be measured using the five-item coping subscale of the Coping Strategies Questionnaire.[@R68]*Self-efficacy*: this will be assessed using the 10-item Pain Self-Efficacy Questionnaire.[@R69]*Sleep, depression and anxiety*: these will be assessed using the single item questions regarding these measures on the Subjective Health Complaints Inventory.[@R70]*Stress*: this will be measured using the seven-item stress subscale of the Depression, Anxiety and Stress Scale.[@R71]*Satisfaction*: participant satisfaction with treatment will be assessed using a single item from the 18-item Patient Satisfaction Questionnaire. "The care that I have been receiving here is just about perfect". 1=Strongly Agree, 2=Agree, 3=Unsure, 4=Disagree, 5=Strongly Disagree.[@R72]

Satisfaction will be assessed at postintervention only while the remaining mediators will be assessed at all time-points (baseline, postintervention, 6 and 12 months follow-up).

Non-specific predictors and moderators of outcome {#s5d}
-------------------------------------------------

*Demographic information*: Participants' age, sex, duration of NSCLBP will be obtained.*Socioeconomic status*: this will be assessed using the Socioeconomic Index.[@R73] This questionnaire provides information about education, employment status, income, ability to pay bills, self-perceived health and satisfaction with number of friends. While aspects of some of these (eg, education) are unlikely to change, some (eg, work status, self-perceived health) may actually be targets of treatment.*Risk of chronicity*: this will be measured using the 10-item short-form Orebro musculoskeletal screening questionnaire.[@R74]*Number of pain areas*: this will be assessed using the Nordic Musculoskeletal Screening Questionnaire.[@R75]*General Health*: general health symptoms will be assessed using the 13-item version of the Subjective Health Complaints Inventory[@R70] and scored as simply the presence or absence of the 13 items.Demographic information will be obtained at baseline only, while the remaining predictors and moderators will be assessed at all the time points.

Timing of outcome measurement {#s5e}
-----------------------------

The aforementioned patient self-report outcomes will be collected at baseline (except satisfaction and costs) and immediately after the intervention by the treating physiotherapist. Costs will only be assessed 6 and 12 months after randomisation. Participants will then be sent copies of the same questionnaires by a blinded assessor (MOK) 6 and 12 months after their randomisation. If a participant does not respond to follow-up, they will be telephoned on up to two occasions each time to ask if they wish to complete the questionnaires.

Blinding {#s5f}
--------

Questionnaires at all time points will be self-completed by the patient. Single blinding will be achieved by having an independent blinded assessor perform the follow-up assessments after 6 and 12 months. Questionnaires will be posted back to the blinded assessor. The blinded assessor will not be treating any of the participants, nor be aware of their group allocation. The statistician conducting the primary data analysis will also be blinded to group allocation. Blinding of the treating physiotherapists and participants will not be possible because they will know the intervention arm to which they have been allocated.

Data and treatment fidelity {#s5g}
---------------------------

A fidelity evaluation where the treating physiotherapists are observed while assessing and treating actual patients from the RCT will be conducted. For every participant in the study, the type and number of treatments received will be recorded. In addition, there will be session-by-session documentation of treatment content for the CFT arm by the treating physiotherapist. Standardised and regular training as well as monitoring and feedback will be given to the physiotherapists to facilitate successful delivery of both treatments. Physiotherapists will complete a series of standardised questionnaires (see online supplementary file 7) assessing their beliefs and attitudes towards CLBP and pain presentations (Health Care Professionals Pain and Impairment Relationship Scale,[@R76] The Pain Attitudes and Beliefs Scale For Physiotherapists,[@R77] The Practitioner Confidence Scale,[@R78] The Attitudes to Back Pain Scale in Musculoskeletal Practitioners,[@R79] and The Neurophysiology of Pain Questionnaire).[@R80] The physiotherapists will also be asked to complete a clinical vignette[@R81] and to provide demographic details, information about their physiotherapy training and general health. To assess quality of communication and interaction, some sessions from both intervention arms will be observed and audio recorded. These recorded sessions will also involve the physiotherapist, patient(s) and an observer completing the Working Alliance Theory of Change Inventory;[@R82] physiotherapists will complete the Communication Assessment Tool.[@R83] Qualitative interviews will be carried out with 8--15 participants from each treatment arm, depending on data saturation. Stratified sampling for these patient interviews will take place and be based on reaching the minimal clinically important difference (MCID) of ODI (30%)[@R84] at 6-month follow-up. Participants will then be randomly selected and interviews will be conducted 6 to 12 months following randomisation to get their views on the care they received.

Statistical analysis {#s5h}
--------------------

Descriptive statistics will be used to summarise participant characteristics in the individualised CFT and class-based intervention. An intention to treat analysis using linear mixed models will be used to compare pain intensity and functional disability between the intervention arms and account for the correlation within-subject over time, while adjusting for differences in participant characteristics at baseline where appropriate. Sensitivity analyses and per protocol analysis will be used to explore whether adherence to the intervention influences the effect of the intervention on the primary outcomes. The analysis of the secondary outcomes will involve linear and non-linear mixed models for continuous and categorical responses where appropriate. Variable selection techniques will be used to identify the most parsimonious set of participant characteristics for inclusion as explanatory variables in each model. An analysis of the potential mediating effects of the secondary outcomes on treatment will be undertaken using the approach of Baron and Kenny.[@R85] In addition, baseline variables will be assessed as non-specific predictors or moderators of treatment by including main and interaction terms in the models. The 5% level of statistical significance will be used throughout the analyses. In addition, the level of clinical significance will be also be reported by comparing any changes in outcome measures to the recognised MCID values[@R84] for standardised outcome measures. A responder to treatment is defined as a \>30% improvement on the ODI.[@R84] All data will be analysed using the IBM SPSS Statistics V. 21 (Armonk, New York, USA) and R 3.1.1.[@R86] Data will be inputted by one researcher (MOK) and a second researcher will randomly double-check 10% of the inputted data to ensure accuracy.

A thematic analysis approach will be used to analyse the qualitative interviews. When all the audio recordings have been transcribed verbatim, the transcripts will be imported into NVIVO 10. The analytic process will be adapted from Sandelowski and Barroso.[@R87] It will involve the following three stages: (1) Extraction of findings and coding of findings for each interview, (2) Grouping of findings (codes) according to their topical similarity and (3) Abstraction of findings---analysing the grouped findings to identify additional patterns, overlaps, comparisons and redundancies to form a set of concise statements, which capture the content of all findings.

Analysis of costs to the participant after intervention {#s5i}
-------------------------------------------------------

The cost analysis of participants after intervention will be undertaken at the follow-up times, 6 and 12 months after initial randomisation. The aims of the analysis will be to identify, measure and compare individual costs incurred by the participants in both groups. Concomitant care, interventions and tests received, hospitalisations and tests, medications, equipment, aids and informal care, travel costs, employment status and work absenteeism will be assessed by a postal questionnaire at these follow-up times and statistical analyses will compare differences between the treatment groups.

Sample size estimation {#s5j}
----------------------

Based on the previous RCT using CFT,[@R39] a sample size calculation estimates that a sample size of 64 in each group will have 80% power to detect a difference in means of 5.0 (disability) and 1.0 (pain) between the two arms of the study, assuming that the common SD is 10.0 (disability) and 2.0 (pain), and using a two-sided 5% significance test. Pilot data collection suggests a slightly larger drop-out rate from the class-based intervention. Consequently, allowing for a 40% dropout rate requires a sample size in each arm of 107, or an overall sample size of 214.

Data and safety monitoring {#s6}
==========================

The Clinical Therapies Department at the University of Limerick, Ireland, will serve as the data coordinating centre responsible for data collection forms, coordination of data transfer and data analysis. Health of participants will be monitored through attending their interventions in the three sites. If any adverse events do take place, and in the unlikely event that harm is suffered, the project management team will liaise with local health service providers. All adverse events will be documented in the final written report of this study. All study data will be stored securely in the University of Limerick. All paper-based documents and data will be stored in a secure filing cabinet. All electronic data will be secured on a password-protected laptop. All documents that contain names or personal identifying information will be stored separately from other study data and identified by code number. Access to files will be limited to research staff involved in the study. The statistician for the final analysis will receive depersonalised data where the participants' identifying information will be replaced by an unrelated sequence of numbers. There are no current plans for granting public access to the full protocol, participant-level data set or statistical code. However, if researchers wish to access the data set (eg, for conduct of secondary analysis or meta-analysis) the project management committee will try to facilitate this.

Dissemination {#s7}
=============

Results will be presented at international scientific conferences and in peer-reviewed publications. An open-access version of the study results will be made available through the University of Limerick\'s institutional repository. Trial participants will also be offered an opportunity to obtain the anonymised, overall study results.

Conclusion {#s8}
==========

This will be the first RCT to compare the clinical effectiveness of individualised CFT and a combined exercise and education class for people with NSCLBP. The study results will provide valuable information about the role of these interventions and has the potential to inform the clinical management of NSCLBP. A 36-month follow-up will be conducted if the 12-month follow-up results suggest this would be useful and if funding is available.
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